Serge Belanger
Stock Analyst at Needham
(4.62)
# 184
Out of 5,072 analysts
390
Total ratings
56.44%
Success rate
23.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLSD Clearside Biomedical | Reiterates: Hold | n/a | $0.41 | - | 17 | Nov 18, 2025 | |
| CRMD CorMedix | Maintains: Buy | $20 → $16 | $9.81 | +63.10% | 19 | Nov 12, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $36 | $19.00 | +89.47% | 2 | Nov 11, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $36 → $34 | $27.72 | +22.66% | 8 | Nov 7, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $40 → $46 | $41.26 | +11.49% | 10 | Nov 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $20 → $18 | $7.18 | +150.70% | 18 | Nov 4, 2025 | |
| LQDA Liquidia | Maintains: Buy | $36 → $52 | $32.63 | +59.36% | 34 | Nov 4, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $55 | $44.72 | +22.99% | 13 | Nov 4, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $22 → $30 | $30.65 | -2.12% | 23 | Oct 28, 2025 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $46 | $46.68 | -1.46% | 26 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $9.69 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $12.17 | +64.34% | 5 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $20 | $13.73 | +45.67% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $14.44 | +93.97% | 21 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $68.13 | +5.68% | 24 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.16 | +158.62% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $13.19 | +66.79% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $31.96 | +6.38% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $7.16 | +207.26% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $9.10 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $23.68 | +26.69% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $4.01 | -0.25% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.58 | - | 1 | Mar 31, 2022 |
Clearside Biomedical
Nov 18, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.41
Upside: -
CorMedix
Nov 12, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $9.81
Upside: +63.10%
Oculis Holding AG
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $19.00
Upside: +89.47%
Amphastar Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $27.72
Upside: +22.66%
NewAmsterdam Pharma Company
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $41.26
Upside: +11.49%
BioCryst Pharmaceuticals
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.18
Upside: +150.70%
Liquidia
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $32.63
Upside: +59.36%
Xenon Pharmaceuticals
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $44.72
Upside: +22.99%
Arcutis Biotherapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $30.65
Upside: -2.12%
Collegium Pharmaceutical
Oct 28, 2025
Reiterates: Buy
Price Target: $46
Current: $46.68
Upside: -1.46%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.69
Upside: -
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $12.17
Upside: +64.34%
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $13.73
Upside: +45.67%
Sep 12, 2025
Reiterates: Buy
Price Target: $28
Current: $14.44
Upside: +93.97%
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $68.13
Upside: +5.68%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.16
Upside: +158.62%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $13.19
Upside: +66.79%
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $31.96
Upside: +6.38%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $7.16
Upside: +207.26%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.10
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $23.68
Upside: +26.69%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $4.01
Upside: -0.25%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.58
Upside: -